ανοιξα αυτο το συντομο θεματακι μονο και μονο για να μην φορτωνουμε τα θεματα αλλων παιδιων.
σχετικα με παρενεσεις χειρουργων μεταμοσχευσης μαλλιων σ ολον τον κοσμο (πλην ελλαδος βεβαια) για χρηση μινοξιδιλης αλλα και φιναστεριδης.
ενδεικτικο κι ενα σχολιο απο ξενο φορουμ.
Minox after a Hair transplant (Hair Transplant)
http://www.forhair.com/role_of_minoxidil_in_the_hair_tr.htm
Several studies have examined the use of minoxidil as an adjunct to hair transplantation surgery in men with androgenetic alopecia.1016-12 18 Kassimir10 Kassimir16 conducted an uncontrolled study in 12 male patients with androgenetic alopecia. Minoxidil 3% topical solution was administered twice daily to the transplant area starting 48 to 72 hours after hair transplant surgery. Two patients demonstrated hair growth without the usual shedding 2–4 weeks post-surgery and two additional patients had regrowth within 4 weeks after postsurgical telogen effluvium. This is far sooner than the typical 3 to 5 months. Bouhanna11 Bouhanna17 conducted an uncontrolled study of minoxidil 2% in 16 male patients with androgenetic alopecia. In this study, mMinoxidil was given for 4 weeks prior to surgery, interrupted for 3 weeks, then restarted and continued for 3 months postsurgery. They The study found that in 71% of grafts, partial or total hair was still growing without usual shedding that occurs 2 to 4 weeks postsurgery. The effectiveness of administering minoxidil prior to hair transplant surgery ws also reported by Roenigk and Berman.12 18 In this double-blind trial, 12 males with androgenetic alopecia were randomized to have either minoxidil 2% topical solution or placebo applied to donor area for 6 weeks prior to transplantation and to recipient areas for 17 weeks after surgery. After 17 weeks, significantly less grafted hair was lost by minoxidil-treated patients (22%) compared with placebo-treated patients (22% vs 52%; P=0.001).
Reported pPotential benefits of regular minoxidil administration following hair transplant surgery included increase in the number of anagen hairs, promotion of hair growth in the transplanted grafts and surrounding area, and reduction of post-surgical shock and telogen effluvium.
Over a decade of successful use of topical minoxidil in the treatment of patients with pattern hair loss and in the nonsurgical setting, coupled with eEncouraging results from the three, small, preliminary studies10-12 of minoxidil topical solution as an adjunct to hair transplant surgery, have facilitated its acceptance and successful use in this setting among the specialists. However, the group was unanimous in advocating for additional, larger clinical studies, which would serve to both strengthen their recommendations and to aid in patient education and compliance.
Results from preliminary clinical trials suggest that minoxidil may speed regrowth in transplanted follicles, prolong the anagen phase, and slow progression of future hair loss. Controlled clinical trials are needed to substantiate these preliminary data and what impact other factors such as patient education and compliance may have in enhancing hair transplant outcomes.
σχετικα με παρενεσεις χειρουργων μεταμοσχευσης μαλλιων σ ολον τον κοσμο (πλην ελλαδος βεβαια) για χρηση μινοξιδιλης αλλα και φιναστεριδης.
ενδεικτικο κι ενα σχολιο απο ξενο φορουμ.
Minox after a Hair transplant (Hair Transplant)
http://www.forhair.com/role_of_minoxidil_in_the_hair_tr.htm
Several studies have examined the use of minoxidil as an adjunct to hair transplantation surgery in men with androgenetic alopecia.1016-12 18 Kassimir10 Kassimir16 conducted an uncontrolled study in 12 male patients with androgenetic alopecia. Minoxidil 3% topical solution was administered twice daily to the transplant area starting 48 to 72 hours after hair transplant surgery. Two patients demonstrated hair growth without the usual shedding 2–4 weeks post-surgery and two additional patients had regrowth within 4 weeks after postsurgical telogen effluvium. This is far sooner than the typical 3 to 5 months. Bouhanna11 Bouhanna17 conducted an uncontrolled study of minoxidil 2% in 16 male patients with androgenetic alopecia. In this study, mMinoxidil was given for 4 weeks prior to surgery, interrupted for 3 weeks, then restarted and continued for 3 months postsurgery. They The study found that in 71% of grafts, partial or total hair was still growing without usual shedding that occurs 2 to 4 weeks postsurgery. The effectiveness of administering minoxidil prior to hair transplant surgery ws also reported by Roenigk and Berman.12 18 In this double-blind trial, 12 males with androgenetic alopecia were randomized to have either minoxidil 2% topical solution or placebo applied to donor area for 6 weeks prior to transplantation and to recipient areas for 17 weeks after surgery. After 17 weeks, significantly less grafted hair was lost by minoxidil-treated patients (22%) compared with placebo-treated patients (22% vs 52%; P=0.001).
Reported pPotential benefits of regular minoxidil administration following hair transplant surgery included increase in the number of anagen hairs, promotion of hair growth in the transplanted grafts and surrounding area, and reduction of post-surgical shock and telogen effluvium.
Over a decade of successful use of topical minoxidil in the treatment of patients with pattern hair loss and in the nonsurgical setting, coupled with eEncouraging results from the three, small, preliminary studies10-12 of minoxidil topical solution as an adjunct to hair transplant surgery, have facilitated its acceptance and successful use in this setting among the specialists. However, the group was unanimous in advocating for additional, larger clinical studies, which would serve to both strengthen their recommendations and to aid in patient education and compliance.
Results from preliminary clinical trials suggest that minoxidil may speed regrowth in transplanted follicles, prolong the anagen phase, and slow progression of future hair loss. Controlled clinical trials are needed to substantiate these preliminary data and what impact other factors such as patient education and compliance may have in enhancing hair transplant outcomes.